A Study of Atezolizumab and Bevacizumab in Hepatocellular Carcinoma

Clinical trial NCT04829383 · COMPLETED

Trial details

NCT number: NCT04829383
Sponsor: Howard S Hochster
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Unresectable Hepatocellular Carcinoma

Start date: 2021-03-22
Primary completion: 2024-06-19
Enrollment: 6

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.